People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

People who switched from obesity injections to Novo's new Wegovy pill continued to lose weight after three months, according to an analysis of real-world data the company presented on Wednesday.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.